TipRanks
Advertisement
Advertisement
Moderately bullish activity in Novo Nordisk with shares down 0.48%
PremiumThe FlyModerately bullish activity in Novo Nordisk with shares down 0.48%
6d ago
Novo Nordisk price target lowered to $40 from $47 at BMO Capital
Premium
The Fly
Novo Nordisk price target lowered to $40 from $47 at BMO Capital
7d ago
Novo Nordisk price target lowered to DKK 296 from DKK 310 at Citi
Premium
The Fly
Novo Nordisk price target lowered to DKK 296 from DKK 310 at Citi
9d ago
AI Predicted Novartis’ $30 Billion Drug Failure. Are Biogen and Takeda Next?
PremiumMarket NewsAI Predicted Novartis’ $30 Billion Drug Failure. Are Biogen and Takeda Next?
12d ago
Novo Nordisk Probes Patient Priorities in German Hemophilia A Study
Premium
Company Announcements
Novo Nordisk Probes Patient Priorities in German Hemophilia A Study
12d ago
Novo Nordisk Expands Treasury Stake as DKK 15bn Buyback Nears DKK 10bn Mark
Premium
Company Announcements
Novo Nordisk Expands Treasury Stake as DKK 15bn Buyback Nears DKK 10bn Mark
13d ago
Moderately bullish activity in Novo Nordisk with shares down 1.06%
PremiumThe FlyModerately bullish activity in Novo Nordisk with shares down 1.06%
18d ago
Novo Nordisk Opens a New Front in Cardiometabolic Care With Early-Stage Anti-Inflammatory Study
Premium
Company Announcements
Novo Nordisk Opens a New Front in Cardiometabolic Care With Early-Stage Anti-Inflammatory Study
18d ago
Novo Nordisk Tests Cagrisema Switch Strategy to Strengthen Its Diabetes Franchise
Premium
Company Announcements
Novo Nordisk Tests Cagrisema Switch Strategy to Strengthen Its Diabetes Franchise
18d ago

Trending

Name
Price
Price Change
S&P 500
―
Dow Jones
―
Nasdaq 100
―